Cases
WellCare Health Plans, Inc. (WCG)
Merger
Overview
Overview
- Date:
- 3/27/2019
- Company Name:
- WellCare Health Plans, Inc.
- Stock Symbol:
- WCG
- Company Name - Buyer:
- Centene Corporation
- Stock Symbol - Buyer:
- CNC
- Status:
- Closed/Complete
- Merger Announcement Date:
- 3/7/2019
NEW YORK, March 27, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of WellCare Health Plans, Inc. (NYSE: WCG) on behalf of stockholders concerning the proposed acquisition of the company by Centene Corporation (NYSE: CNC).
Pursuant to the proposed transaction, announced on March 27, 2019 and valued at $17.3 billion, WellCare stockholders will receive $120.00 in cash and 3.38 shares of Centene for each share of WellCare common stock owned. The investigation focuses on whether WellCare and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own WellCare shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.
Pursuant to the proposed transaction, announced on March 27, 2019 and valued at $17.3 billion, WellCare stockholders will receive $120.00 in cash and 3.38 shares of Centene for each share of WellCare common stock owned. The investigation focuses on whether WellCare and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own WellCare shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.